Lamone 150 Stella tablet treats HIV infection (6 blisters x 10 tablets)

Dosage form Box of 6 blisters x 10 tablets
Specifications Stella

Uses

indications

Lamone 150mg drugs are indicated to treat HIV infection in adults and children in combined Retrovirus resistance therapy.

Pharmacokology

There is no reported data.

Dynamic pharmacokinetics

There is no reported data.

Before taking Lamone 150 Stella tablet treats HIV infection (6 blisters x 10 tablets)

How to use

Lamone 150mg is used by oral, or not with food. To ensure the full dose, it is best to swallow the whole pill, not crushing the pill.

In addition, if the patient cannot swallow the pills, can crush the pills and add a small amount of food or liquid and use immediately.

Dosage

Adults, adolescents and children (weighing ≥ 25 kg):

Take a dose of 300 mg/day, can take 150 mg (1 tablet) x 2 times/day or 300 mg (2 capsules) x 1 time/day.

Children (weight

Children weigh ≥ 20 kg to Adults and children (weighing ≥ 25 kg):

CLCR ≥ 50 ml/minute: The starting dose is 300 mg (2 tablets) or 150 mg (1 tablet), the maintenance dose is 300 mg (2 tablets) x 1 time/day or 150 mg (1 tablet) x 2 times/day. Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What to do when using overdose?

What to do when you forget 1 dose? However, if the time to relax with the next dose is too short, skip the dose and continue the calendar of the drug. Do not use double dose to compensate for missed dose.

Side Effects

Unwanted effects when using Lamone 150mg that you may encounter.

Common: headache, insomnia, cough, symptoms in the nose, nausea, vomiting, pain or abdominal cramps, diarrhea, rash, hair loss, joint pain.

Uncommon: neutropenia and anemia (both sometimes severe), thrombocytopenia, liver enzymes increased fleeting (AST, ALT).

When experiencing side effects of the drug, patients need to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

contraindicated

Lamone 150mg contraindicated drug in the following cases:

Hypersensitivity to the active ingredient or any drug of the drug.

Patients with severe renal impairment.

Be cautious when using

lamivudine does not cure HIV infection, they continue to carry HIV infection, including opportunistic infections. Patients still have to be monitored and cared for continuously. Lamivudine does not reduce the risk of HIV transmission, and they have to use condoms to protect their partners.

Lactic acid infection may occur after a few months of treatment. Be careful when using nucleosid similar substances for any patient (especially obese women) with enlarged liver, hepatitis or have risk factors for liver and fatty liver.

In patients with HIV infected with severe immunodeficiency at the beginning of the combination of anti -Retrovirus (Cart) drugs, there may be asymptomatic inflammatory reactions or opportunistic infections and cause serious clinical or severe clinical diseases. For example, cytomegalovirus retinitis, bodybacterium infection with body and/or local or local and pneumonia caused by pneumocystis jirovecii.

It is necessary to stop using lamivudine as soon as the signs, clinical symptoms or other unusual test results are suspected of pancreatitis.

Recommendations should not be used for lamivudine.

Patients with medium to severe renal impairment, lamivudine's last selling time in plasma increases due to decreasing clearance, so adjusting the dose.

Patients with chronic hepatitis B or C and treated with Retrovirus anti -Retrovirus therapy are at high risk of unwanted effects in severe liver and can be fatal. In case of hepatitis B or C, please refer to the relevant information of these products.

Cases of bone necrosis have been specially reported in patients with HIV -infected and/or exposed exposures with combined Retrovirus resistance (cart). Patients should be consulted medical advice if pain and joint pain, stiffness or difficult travel.

Do not use lamivudine with other drugs that contain lamivudine or drugs containing emtricitabine.

Do not recommend combining lamivudine with cladribine.

According to the general principle, when deciding to use Retrovirus anti -Retrovirus drugs in the treatment of HIV infection in pregnant women and thereby reducing the risk of HIV transmission from mothers to infants, animal data should be considered as well as clinical experiences in pregnant women.

Recommended HIV -infected women must not breastfeed in any case to avoid HIV infection.

Drug interaction

drug interactions may affect the activity of the drug or cause side effects. Should notify the doctor or pharmacist a list of drugs and functional foods you are using. Do not use or increase or decrease the dose of the drug without the guidance of a doctor.

Storage

Leave a cool place, avoid light, temperature below 30⁰C.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.